This study provides preliminary insights into the potential mechanisms and interactions of CD28+PD-1+ Tc cells in HCC, providing a novel perspective for understanding the TME in HCC and new approaches for predicting treatment responses and prognosis. The gene discussed is CD28; the disease is hepatocellular carcinoma.